THRY Q1 2026 Earnings Significant EPS Beat Surprises Market MCK Q1 2026 Earnings EPS Slightly Exceeds Estimates Amid Steady Operational Performance Outlook Therapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Surges 29 HOFT Q1 2026 Earnings EPS Misses Estimates Yet Stock Rises on Underlying Strength GENB Q1 2026 Earnings PreRevenue Biotech Misses EPS Estimates Shares Rise on Operational Progress ADMA Biologics Q1 2026 Earnings EPS Miss Weighs on Shares as Profitability Path Remains in Focus